Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hibiscus sabdariffa extract is a natural product derived from the calyces of the Hibiscus sabdariffa plant. It is widely consumed as a beverage (commonly known as "hibiscus tea") and used in traditional medicine for its potential health benefits. The extract contains various bioactive compounds such as anthocyanins (including delphinidin 3-sambubioside and cyanidin 3-sambubioside), chlorogenic acid, myricetin 3-arabinogalactoside, quercetin 3-rutinoside and others[5]. Its primary investigated mechanisms include antihypertensive effects (possibly through vasodilation or diuretic action), mild laxative activity due to fruit acids in the plant[1][3], metabolic/lipid-lowering effects[4], anti-inflammatory properties[4], and possible antibiotic-like actions[1]. While it has been studied for lowering blood pressure and cholesterol levels—especially in people with hypertension—clinical evidence remains limited for most indications. Hibiscus sabdariffa extract is not developed by a single pharmaceutical company but is produced by various manufacturers worldwide primarily as a dietary supplement or food ingredient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hibiscus sabdariffa extract.